Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06605989

Nostril Side on Epistaxis

The Effect of Nostril Side on Epistaxis During Nasotracheal Intubation

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
208 (estimated)
Sponsor
Seoul National University Hospital · Academic / Other
Sex
All
Age
19 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to investigate the effect of the nostril side on epistaxis during nasotracheal intubation.

Detailed description

This prospective randomized controlled study was approved by the IRB of our institute. Patients requiring nasotracheal intubation will be screened for eligibility for the study. Then, patients will be randomized to one of two groups; (Group I: tube will be inserted through the left nostril and advanced into the oral cavity / Group II: tube will be inserted through the right nostril and advanced into the oral cavity). After induction of anesthesia and muscle relaxation, the preformed nasal RAE (Ring-Adair-Elwyn) tube will be inserted via the nostril, which is assigned to each patient according to the group, approximately 3-4 cm. Next, an anesthesiologist will advance the tube into the oral cavity. After the tube is placed in the oral cavity, the anesthesiologist will perform nasotracheal intubation with Magill forceps. After that, an investigator will check the occurrence of epistaxis due to nasotracheal intubation and its severity with a fiberoptic bronchoscope. After obtaining all data, investigators will analyze the incidence of epistaxis and its severity between the two groups.

Conditions

Interventions

TypeNameDescription
PROCEDURENasotracheal intubationFor nasotracheal intubation, the nasal RAE tube will be first inserted through the left nostril for patients in the left nostril side arm. For nasotracheal intubation, the nasal RAE tube will be first inserted through the right nostril for patients in the right nostril side arm.

Timeline

Start date
2024-09-26
Primary completion
2026-02-28
Completion
2026-02-28
First posted
2024-09-20
Last updated
2026-02-11

Locations

2 sites across 1 country: South Korea

Source: ClinicalTrials.gov record NCT06605989. Inclusion in this directory is not an endorsement.